Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”Marc‐Oliver Grimm, Joan Palou, Anup Patel et al.|European Urology|2020Cited by 132
Microhematuria assessment an IBCN consensus—Based upon a critical review of current guidelinesBernd J. Schmitz‐Dräger, Lambertus A. Kiemeney, Eva Charlotte Kuckuck et al.|Urologic Oncology Seminars and Original Investigations|2016Cited by 33
AI allows pre-screening of FGFR3 mutational status using routine histology slides of muscle-invasive bladder cancerPierre‐Antoine Bannier, Markus Eckstein, Charlie Saillard et al.|Nature Communications|2024Cited by 18
New horizons in bladder cancer researchJoost L. Boormans, Bernd J. Schmitz‐Dräger, Ellen C. Zwarthoff et al.|Urologic Oncology Seminars and Original Investigations|2019Cited by 10